-50% when compared with controls (p = 0.006 and 0.0004, respectively). Mild hypotension induced by nimo dipine did not aggravate the ischemic insult. The ischemic core volumes, however, were 50-75% smaller than the 24-h infarct volumes generated in a similar paradigm that demonstrated 20-30% infarct reduction with continuous nimodipine treatment. These results suggest that nimo dipine pretreatment attenuates the severity of early focal cerebral ischemia, but that with persistent ischemia, cor tex surrounding the ischemic core undergoes progressive infarction and the early benefit of nimodipine treatment is only partly preserved. Key Words: Calcium channel blocker-Focal cerebral ischemia-Middle cerebral ar tery occlusion-Nimodipine-Spontaneously hyperten sive rat.
tection, however, is unclear. Although a nimo dipine-mediated improvement in CBF would appear to be a likely mechanism (Scriabine et aI., 1985) , cytoprotection may also have involved nimo dipine's anticonvulsive properties (Meyer et aI., 1986a,c; Siesjo, 1986) or its capacity to directly an tagonize pathologic calcium entry into neurons (Scriabine and van den Kerckhoff, 1988; Scriabine et aI., 1989; Siesjo and Bengtsson, 1989) . Nonvas cular mechanisms have been invoked to explain ni modipine's ability to improve cerebral acidosis (Hakim, 1986; Hakim, 1988, 1989) and offset pathologic EEG changes and intracellular cal cium entry (U ematsu et aI., 1989) without altering CBF in focal cerebral ischemia.
This study examines the effect of nimodipine pre treatment on CBF and cerebral edema in awake rats 2.5 h after the tandem occlusion of the MCA and common carotid artery (CCA). The paradigm em ploys the same experimental conditions that yielded a 20-30% decrease in the 24-h cortical infarct vol-ume with nimodipine treatment (Jacewicz et aI., 1990) . The selection of the time point for the CBF study (2.5 h after MCAJCCAO) represents a critical juncture in this model when as much as half of the MCA territory is in a dynamic transition between reversible injury and infarction (Jacewicz et aI., 1986 (Jacewicz et aI., , 1989 Brint et aI., 1987; B. A. Kaplan et aI., in preparation) . Since hypotension induced by anes thesia (Osborne et aI., 1987) or by nimodipine (Mo hamed et aI., 1984) can potentially offset any CBF increase and exacerbate ischemic damage, we also examined the influence of blood pressure on the severity of ischemia and on edema formation.
METHODS

Anesthesia exposure
To minimize anesthesia (halothane) exposure during the ischemic interval, the surgical procedures were per formed in three steps over 2 consecutive days. On the first day, preparative surgery (60 min in duration) includ ing placement of a loose carotid artery ligature, venous catheters, and the Alzet microosmotic drug delivery sys tem. On the second day (following an overnight fast), the femoral artery was cannulated under very brief (5-1 0 min) anesthesia. The animals recovered for 3 h and then un derwent MCNCCAO in a procedure that required 20--30 min to complete. Halothane was immediately discontin ued upon induction of cerebral ischemia. The animals awoke 10--15 min later and remained conscious thereaf ter.
Preparative surgery
Adult male (260--330 g) Wistar (Hilltop) and spontane ously hypertensive rats (SHRs; Charles River) were anesthetized with 2% halothane in a mixture of 70% nitrogenl30% oxygen. Surgical fields were shaved and washed several times with a Povidone-iodine solution. A right paramedian cervical incision permitted cannulation (PE-50) of the external jugular vein (for later injection of the blood flow marker [14C]iodoantipyrine) and place ment of a loose ligature (4-0 silk) around the right CCA. A 1O-/-LlIh microosmotic pump (Alza Corp.) was primed in 0.9% saline at 37°C for a minimum of 3 h and implanted subcutaneously (Theeuwes and Yum, 1976; Urquhart et aI., 1984) . The femoral vein was cannulated and con nected to the pump via subcutaneous tubing (PE-90) filled with 0.9% saline. The animals awoke and equilibrated overnight for nimodipine administration on the following day.
The next morning, the animals were reanesthetized with halothane and the femoral artery was cannulated (PE-50) for blood pressure monitoring, blood sampling, and the terminal CBF study. The animals awoke, and 30-45 min later, baseline physiologic variables were ob tained just prior to initiation of nimodipine treatment.
Pretreatment with nimodipine
Nimodipine (courtesy of Miles Laboratory) was freshly solubilized in polyethylene glycol 400 for intravenous in fusion at 2 /-Lg/kg/min by the microosmotic pump. The rats were placed in a restraining box. Via an external connec tion, the Alzet pump was momentarily detached, and the J Cereb Blood Flow Metab, Vol. 10, No.6, 1990 nimodipine solution was slowly advanced into the subcu taneous tubing (total tubing volume of 0.1 ml) connected to the femoral vein. A sudden drop in blood pressure (10--30 mm Hg) indicated systemic entry. Control animals showed no blood pressure change upon receiving a com parable amount (0.1 m!) of polyethylene glycol 400 for infusion at 10 /-LlIh. The tubing containing the nimodipine or vehicle was reattached to the Alzet pump, and the animals were returned to their cages where they equili brated for 2 h before MCAICCAO surgery. To avoid de composition during handling and administration, nimo dipine was shielded from light with aluminum foil. The Alzet pump, its tubing, and connections were later exam ined (postmortem dissection) to ensure their integrity and the efficacy of drug delivery during a total treatment pe riod of -5 h.
MCAICCAO
Under halothane anesthesia, the right MCA was oc cluded using a transtemporal approach (Coyle, 1982; Brint et aI., 1988) . After partial removal of the temporalis muscle, a 2-mm burr hole was drilled in the underlying bone 2-3 mm rostral to the fusion of the zygoma with the squamosal bone. A continuous, gentle flow of 0.9% saline during drilling prevented any heating of the underlying cortex. Halothane was reduced to 0.5%, and the previ ously placed carotid ligature was tightened. The dura was then pierced 0--1 mm above the rhinal fissure Gust distal to the lenticulostriate arteries), and the exposed MCA was gently lifted (1 mm) off the cortical surface by an 80-/-Lm stainless-steel hook. The artery was severed by application of electrocautery (Geiger) to the hook, and halothane was immediately discontinued. In five vehicle and five nimodipine-treated animals (SHRs), there fol lowed a brief observation period (5-10 min) of the vascu lar response to MCAICCAO as seen through the partly shaved, translucent temporal bone overlying the distal MCA. After treatment with 5% lidocaine ointment, all surgical wounds were closed with either metal wound clips or a running silk suture, and the animals were re turned to their cages. They awoke 10--15 min after MCAI CCAO.
Physiological monitoring
During MCAICCAO surgery, blood pressure was con tinuously monitored (Beckman R 511 polygraph), arterial blood gases and pH serially measured (Corning 158 pHI blood gas analyzer), and body temperature maintained at 37°C using a rectal thermistor coupled to a heating lamp (Yellow Springs Instruments, Yellow Springs, OH, U.S.A.). Physiologic variables were measured at four time points: just prior to nimodipine administration, be fore MCAICCAO surgery, at the time of MCAICCAO, and at the time of the CBF study.
Quantitative CBF
Cortical blood flow was measured by a standard indi cator-fractionation technique (Van Vitert and Levy, 1978; Van Uitert et aI., 1981) using [14C] iodoantipyrine as the blood flow marker. Two hours and 15 min after MCN CCAO, the rats were again placed in a restraining box and allowed to acclimatize over 15 min. [l4C]Iodoantipyrine was injected as a bolus (30 /-LCi in 0.4 ml of 0.9% saline) into the jugular venous cannula, while femoral artery blood was withdrawn into a syringe using a Harvard pump. The animal was decapitated 5-6 s after injection of the isotope, and the tail artery cannula was severed si multaneously. The short circulation time minimizes any back-flux error, which may complicate this technique (Patlak et aI., 1984) . Brains were rapidly removed, frozen in Freon over dry ice, cut into 20-lLm-thick coronal sec tions at -2SOC, and exposed to Kodak SB-5 film for 14 days. Aliquots (25 ILl) of the withdrawn blood were dis solved in 0.5 ml of Protosol (Dupont-NEN) and mixed with 10 ml of Toluene-Omnifluor (Dupont-NEN), and 14C was measured in a Searle Mark III scintillation counter. The optical densities of the SB-5 autoradiographs were measured regionally in the cortex and in selected brain regions with a Quantimet 970 Image Analyzer (Cambridge Instruments). Correlation to [14Clmethylmethacrylate standards (Dupont-NEN) exposed with the brain sections allowed quantification of the 14C concentration in the sec tions and calculation of regional CBF (rCBF) ( Van V itert and Levy, 1978; Van Vitert et aI., 1981) .
Cortical regions with CBF of < 25 mi/IOO glmin and < 50 mlil00 g/min were serially imaged (500-lLm intervals), and their areas were quantified and summed by an itera tive program (Quantimet 970 image analysis) to calculate the cortical volume below each specified CBF level. The latter procedure was done by an individual blinded to treatment group identity and rat strain. The "ischemic core" in this communication is defined as cortex with CBF of < 25 mi/IOO g/min that has in all likelihood sus tained early neuropathological damage (Tyson et al., 1984) . "Moderately ischemic" cortex refers to tissue with CBF of 25-50 mlilOO g/min in which ischemic injury is presumably still reversible and therefore contains the so called "ischemic penumbra" surrounding the infarcted zone (Astrup et aI., 1981) .
Cortical edema volume
The measurement of edema volume followed a method developed by us (Brint et al., 1988; lacewicz et aI., 1990) and is based on the assumption that the changes in cor tical volume during the first 24 h of permanent ischemia are due chiefly to edema formation within and around the infarct. Since the brain water content increases from 79% (normal) to a maximum of 86% in a mature infarct (F. B. Meyer and W. A. Pulsinelli, unpublished observations), artifactual volume changes due to the volume expansion of water during freezing can be neglected. The coronal brain sections on the autoradiographs therefore closely reflect in situ brain volume changes. The total left (non ischemic) cortical volume in each brain was calculated (Quanti met 970 image analysis) and subtracted from the total cortical volume of the right (ischemic) side to yield a volume difference by which the cortex containing both infarcted and noninfarcted tissue exceeded that of the nonischemic side. This difference in cortical volumes, for the purposes of this study, is defined as "edema volume." Because right-left differences are not calcu lated for individual sections but for the entire neocortex, this method does not require that coronal sections be per fectly symmetric, but only that they include the entire frontal to occipital length of the brain. The quantification of the edema volume was also done by an individual blinded to treatment group identity and rat strain.
Statistical analysis
Blood flow data, edema volume, and physiologic pa rameters are expressed as means ± SD. A two-way anal ysis of variance was used to evaluate the effect of nimo dipine and rat strain on (a) the volume of the ischemic core (CBF < 25 mlllOO glmin), (b) the volume of moder ately ischemic cortex (CBF = 25-50 ml/l00 glmin), and (c) the volume of cortical edema. A simple linear corre lation program was employed to determine if edema ac cumulation was proportional to the severity of the isch emic insult (i.e., to the cortical volume with CBF of < 25 ml/IOO glmin or < 50 ml/l00 g/min). An analysis of co variance was used to determine if nimodipine influenced the relationship between the volume of cortical edema and (a) the volume of cortex with CBF of < 25 mlil00 glmin and (b) the volume of cortex with CBF of < 50 mill 00 glmin (i.e., to determine if nimodipine exerted an tiedema effects that were independent of improvements in CBF). A linear correlation program was used to deter mine if the MABP at the time of MCAICCAO or at the time of the CBF study influenced the volume of edema, the volume of the ischemic core, the amount of cortex at risk for infarction (CBF < 50 mlilOO glmin), or the lowest measured rCBF (i.e., nadir rCBF) within the ischemic core. Scatter diagrams were plotted, and the correlation coefficients (r) were calculated.
RESULTS
Physiological variables
Nimodipine caused mild hypotension (10-20% decrease in MABP) that was accentuated by halo thane anesthesia ( Table l) . The blood pressure, : ::h (fj M. JACEWICZ ET AL . however, recovered rapidly after halothane was dis continued (e.g., rising by 13-24 mm Hg during the first 3 min after MCAICCAO in SHRs). Anesthesia produced a mild, transient respiratory acidosis, but, with the exception of MABP, physiologic variables were comparable in the nimodipine-treated and control animals. Body temperatures averaged 37SC in both groups (range 36.5-38SC). At the time of the CBF study, the animals showed drinking and grooming behavior and appeared to be recov ering satisfactorily from surgery.
Effect of nimodipine pretreatment on cortical ischemia
The tandem occlusion of the MCA and CCA in the rat caused an immediate, brief « I-min dura tion) vasodilatation followed by moderate to severe vasoconstriction of pial arteries in cortical regions that suffered profound ischemia (see below). The vasoconstrictor effect was readily observed through the translucent, partly shaved, but intact bone over lying the MCA 1-3 mm distal to the occlusion site. In a separate study, the bone and dura overlying the constricted MCA were removed, and the vasocon striction was found to be reversible by gently bath ing the exposed cortex with 0.9% saline (unpub lished observations).
The Quantimet 970 Image Analyzer provided rCBF measurements of high resolution (i.e., 0,5 x 0,5 mm rCBF), permitting serial rCBF quantltIca tion at various depths of cortex along the coronal curvature. Blood flow changes in a 0.5-mm band midway between the cortical surface and the sub cortical white matter (Fig. 1) were representative of rCBF changes through the thickness of the cortex except for 0-15% greaterrCBF in the superfi�ial cortical layers. The rCBF at 2.5 h after MCAI CCAO showed a transition from close to normal values in the paramedian cortex to its nadir some 2-8 mm away along the coronal plane (Fig. I, top) . Interanimal variability in rCBF was more evident in the MCA periphery than in the central "ischemic core" (i.e., rCBF was more variable in the pari eto-occipital cortex, near the paramedian cortex, and near the rhinal fissure).
Nimodipine pretreatment partly offset the vaso constriction induced by MCAICCAO (observed through translucent bone), and 2.5 h later the isch emic gradient across the cortex (Fig. I, bottom) was less pronounced at every coronal level (i.e., indi vidual rCBF profiles were shifted upward, leaving fewer points below 25 mlllOO glmin). The resulting volume of the ischemic core (CBF < 25 mlllOO gI min) in nimodipine-treated animals was 50% smaller than in controls (Table 2) , and the nadir rCBF was attenuated as well. The improved circulation in the "ischemic core" occurred without shunting CBF (i.e., "vascular steal") from the adjacent "mod erately" ischemic cortex (CBF = 25-50 mlllOO gl min), which remained comparable in volume to con trols (Table 2) .
Although adjoining the ischemic cortex, the lat eral basal ganglia suffered minor reductions in CBF (Table 3 ) that were insufficient to cause histologic damage in this model (Brint et ai., 1988; Jacewicz et aI., 1990) . In 29 separate regions of the left (nonis chemic) cortex, absolute rCBF measurements in SHRs varied from 92 ± 25 to 154 ± 57 mlllOO glmin in vehicle-treated animals and from 115 ± 28 to 162 ± 51 ml/lOO g/min in nimodipine-treated animals, a 0-20% rCBF increase over controls that did not reach statistical significance. Wi star animals also showed a variable increase in nonischemic rCBF with nimodipine treatment that did not attain statis tical significance (data not shown).
Effect of nimodipine pretreatment on cortical edema
Nimodipine-treated animals developed -50% less edema than controls (p = 0.0004; Table 4 ). The edema was evident on the autoradiographs as an enlargement in cortical thickness that was most prominent in densely ischemic regions (data not The percentage indicates the approximate amount of the total cortex being perfused at the specified CBF level. SHR, spontaneously hypertensive rat; rCBF, regional CBF. a p = 0.034, vehicle vs. nimodipine (two-way analysis of variance). b p = 0.007, vehicle vs. nimodipine (two-way analysis of variance). shown). Scatter plots of individual edema volumes and cortical volumes (mm 3 ) with CBF of < 25 mIl 100 g/min (Fig. 2) and < 50 mlllOO g/min (Fig. 3) suggest that the amount of edema is linearly pro portional to the severity of the ischemic insult in both nimodipine-treated and control animals (r = 0.5-0.8). The exact blood flow boundaries of cortex in which the edema is generated or to which it is confined, however, have not been identified. None theless, nimodipine pretreatment appears to reduce the amount of edema that accumulates for any given ischemic insult, whether the insult is characterized by the volume of the ischemic core (CBF < 25 mIl 100 g/min) or by the larger volume of cortex (CBF < 50 mIllOO g/min) that also contains the threatened "ischemic penumbra." Because the two regression lines in Fig. 3 (but not Fig. 2 ) were found to be parallel, an analysis of covariance was used to de termine if the mean edema volume for nimodipine treatment differed from controls after adjusting for the nimodipine effect on cortical volume with CBF of < 50 mIll 00 g/min (i.e., this was the equivalent to determining whether the y-intercepts differ). The separation of the regression lines was found to be highly significant (p < 0.004), suggesting that nimo- Edema is determined by subtracting the total left (nonisch ernie) cortical volume from the total right (ischemic) cortical vol ume. The percentages describe the approximate fraction of 24-h edema volume already present by 2. 5 h after MCA/CCAO. SHR, spontaneously hypertensive rat. CORllCAL VOLUME (mm3) WITH CBF 25 mi/l00g/min
A scatter diagram shows a proportional (linear) in crease in the volume of edema as the cortical volume with CBF of <25 ml/100 g/min increases. Because the changes in CBF and edema were very similar in the Wistar and sponta neously hypertensive rats, the data from the two groups have been combined. The regression line (solid) for the nimo dipine-treated animals lies below the regression line (dashed) for vehicle-treated animals, which suggests that ni modi pine-treated animals may develop less edema than con trols even when the ischemic insults are of comparable se verity.
dipine was also exerting an anti edema effect that was independent of CBF improvement.
Effect of MABP on cortical ischemia and edema
The MABP did not influence the severity of isch emia in either the nimodipine-treated or the control groups. A simple linear regression analysis revealed no relationship between MABP (either at MCAI CCAO or at the time of the CBF study) and the lowest measured rCBF, the size of the ischemic core, or the volume of edema in either nimodipine treated animals or controls (r < 0.25 in all in stances). A scatter diagram (Fig. 4) CORTICAL VOLUME (mm3) W!TH CBF 50 ml/l OOg/min
A scatter diagram shows a proportional (linear) in crease in the volume of edema as the cortical volume with CBF of <50 mll100 g/min increases. As in Fig. 2 , the nimo dipine-treated animals develop less edema than controls over a wide range of comparable ischemic insults (p < 0.004, analysis of covariance). study. Despite mild hypotension, the nimodipine treated animals exhibited smaller ischemic core vol umes than controls.
DISCUSSION
This study demonstrates that nimodipine pre treatment attenuates focal cortical ischemia and edema formation in awake rats 2.5 h after ischemia onset. The level to which rCBF falls is tempered, and the volume of the ischemic core (CBF < 25 ml/100 glmin) is reduced by �50%. The improve ment in CBF occurs without a "vascular steal" from nearby moderately ischemic cortex (CBF = 25-50 ml/lOO g/min), which remains comparable in volume with that of controls. Edema accumulates in proportion to the severity of the ischemic insult and measures 50% less in volume in the nimodipine treated animals. The hypotension that accompanies nimodipine treatment is modest and affects neither the depth nor the extent of ischemia in this model.
Previous studies have also found that nimodipine pretreatment attenuates the severity of focal cere bral ischemia (Mohamed et al., 1985; Meyer et al., 1988) . General anesthesia, however, may have con tributed to the CBF increases (Kanda and Flaim, 1986; Seyde et al., 1986) , raising doubt as to whether nimodipine can increase CBF in the isch emic brain of conscious animals. The presence of anesthesia can markedly alter the way certain drugs (e.g., MK-80l) affect blood pressure, CBF, and ce rebral glucose utilization (Park et al., 1989) . For these reasons, the overlap between anesthesia ex posure and the ischemic interval was kept to a min imum in the current study. The results show that in awake animals, nimodipine pretreatment increases J Cereb Blood Flow Metab, Vol. /0, No, 6, 1990 rCBF in ischemic cortex but causes only a small (0-20%) heterogeneous rise in rCBF on the nonisch emic side. The study is in agreement with prior ob servations that severe focal cerebral ischemia causes the pial arteries of the cortex to vasocon strict (Waltz and Sundt, 1967; Teasdale et al., 1981 Teasdale et al., , 1983 Meyer et al., 1986b Meyer et al., , 1988 and that nimodipine pretreatment can blunt this vasoconstrictive effect (Mohammed et al., 1985; Meyer et al., 1988) .
Accompanying the 50% reduction in the size of the ischemic core is a 50% decrease in the differ ence between the right (ischemic) and left (control) total cortical volumes (i.e., defined as edema vol ume) in the nimodipine-treated groups (Table 4) , which we believe represents an antiedema effect of nimodipine treatment. Although a right-left differ ence in total cortical volume could arise from an increase in the cerebral blood volume on the isch emic side, cerebral blood volume has been found to increase by <2% in the early hours after MCAO (Tomita et al., 1980) , an increment insufficient to account for the much larger swelling of ischemic cortex in this model. The right-left difference in cor tical volume is best explained by brain edema, which can develop rapidly after MCAO (Schuier and Hossmann, 1980) . However, actual water con tent was not directly measured in these experi ments, and there remains a possibility that pro cesses other than edema formation may have made a minor contribution to brain swelling.
Given the above qualifications concerning edema volume, this study confirms the benefit of increased blood flow to the ischemic brain and demonstrates that cerebral edema is not exacerbated as can occur in some experimental paradigms of focal cerebral ischemia (Harris et al., 1982) . Of the final edema volume generated 24 h after MCNCCAO (Jacewicz et al., 1990) , �26% is already present 2.5 h after ischemia onset in nimodipine-treated SHRs versus 39% in controls (Table 4) . Thus, not only is total edema volume decreased in nimodipine-treated an imals, but the rate of edema accumulation appears attenuated. This suggests that in addition to de creasing the extent of infarction, nimodipine treat ment may also delay the infarct process, perhaps by a direct effect on neural tissue. This hypothesis can be tested by comparing the volume of edema to the severity of the ischemic insult in nimodipine-treated animals versus controls (i.e., given comparable ischemic insults, does the presence of nimodipine cause less edema to accumulate?). Because neither the CBF threshold for edema formation nor the CBF boundaries that contain early edema are known for this model, the edema volume was com pared with the volume of cortex at two ischemic thresholds: CBF < 25 ml/IOO g/min and CBF < 50 ml/l00 glmin (Figs. 2 and 3) . Edema accumulates in proportion to the ischemic insult for both CBF thresholds, but the nimodipine regression line lies below that of controls (Figs. 2 and 3 ). An analysis of covariance indicates that the separation between the two parallel lines is statistically significant for CBF of <50 ml/l00 g/min. In animals with equal volumes of cortex with CBF of <50 ml/IOO g/min, nimodipine-treated animals accumulate less edema than untreated animals. This observation is consis tent with the hypothesis that nimodipine can retard the formation of edema independently of its effect on CBF, perhaps by acting directly on neural tissue (Scriabine and van den Kerckhoff, 1988; Scriabine et aI., 1989) . The higher CBF boundary «50 mi/IOO glmin), which includes tissue generating the edema and much of the cortex into which edema diffuses, is of particular interest because in the absence of recirculation, this region progresses to infarction (see below).
The ischemic core volumes (CBF < 25 ml/IOO glmin) with or without nimodipine treatment mea sured at 2.5 h after MCA/CCAO do not coincide with the two-to threefold larger volumes of cortical infarction measured 24 h after MCA/CCAO (J acewicz et aI., 1990) . This indicates that the sur rounding moderately ischemic cortex (CBF = 25-50 ml/l00 g/min) progresses to infarction over time. It also suggests that either the CBF threshold for infarction is considerably greater than 25 mi/IOO g/ min in this model or CBF continues to deteriorate in the moderately ischemic cortex. In the case of the hypertensive rat, preliminary work suggests that the CBF threshold for cortical infarction with pro longed ischemia is at least 35 ml/l00 g/min and that the volume of tissue with CBF below 35 mi/IOO g/ min gradually enlarges after MCAICCAO (Jacewicz et aI., 1989, unpublished observations) . That con siderable ischemic injury can occur in rat brain at blood flows of 30-35 ml/IOO g/min is supported by other observations that show cerebral acidosis (Harris and Symon, 1984) and major changes in ce rebral gene expression at this CBF threshold (Jacewicz et aI., 1986) . By 4 h after MCAICCAO, cortical infarction is nearly complete, and there is little benefit from recirculation over the next 20 h (Brint et aI., 1987; B. A. Kaplan et aI., in prepara tion) . Thus, at a critical time when the infarct pro cess is undergoing dynamic expansion (Brint et aI., 1987; Jacewicz et aI., 1989; B. A. Kaplan et aI., in preparation) , nimodipine markedly attenuates isch emic injury. However, the impressive early benefit . evolves to a more modest, but more permanent re duction of 20-30% in infarct volume (Jacewicz et aI., 1990) . It raises the intriguing possibility that ad ditional timely interventive measures (e.g., recircu lation by thrombolytic therapy, N-methyl D-aspartate receptor blockade) might capture and preserve more of nimodipine's early benefit.
Because cerebral ischemia impairs autoregulation (Kontos, 1986) , we anticipated that blood pressure would influence the severity of the ischemic insult. However, no correlation was found between the MABP (at the time of ischemic onset or at the time of the CBF study) and different markers of ischemic injury (e.g., volume of the ischemic core, edema accumulation) in either nimodipine-treated animals or controls. We have observed a similar lack of cor relation between MABP and infarct volume in this model (Jacewicz et aI., 1990) . With the rapid recov ery from halothane anesthesia, blood pressure quickly reaches a range where its influence on ce rebral perfusion appears secondary to other more critical factors (e.g., availability of vascular collat erals, presence of nimodipine). As a result, the mild hypotension associated with therapeutic doses of nimodipine is insufficient to intensify ischemic injury.
Until recently, treatment of human stroke has been of unproven efficacy. Nimodipine, a potent cerebral vasodilator (Scriabine et aI., 1985 (Scriabine et aI., , 1989 , has been found to decrease permanent ischemic deficits that can complicate subarachnoid hemor rhage from a ruptured aneurysm (Allen et aI., 1983; Philippon et aI., 1986; Ohman and Heiskanen, 1988; Petruk et aI., 1988; Pickard et aI., 1989) . In ischemic stroke, morbidity and mortality may be improved by early treatment with nimodipine (Gelmers et aI., 1988) , but whether this is due primarily to nimo dipine's systemic effects or to protection of the ischemic brain is controversial, and more recent data suggest that nimodipine does not protect the ischemic brain if treatment is delayed beyond 12 h after stroke onset (Mohr et aI., 1989 , personal com munication). Another major reason for the contro versy has been the lack of a clear, reproducible therapeutic effect under different experimental con ditions. What determines nimodipine efficacy has been slowly but incompletely clarified. Genetic fac tors that govern intracerebral vascular collateraliza tion are most likely responsible for the profound influence that animal species and strain have on the variability of ischemic damage following MCAO (pay an et aI., 1965; Coyle and Jokelainen, 1983; Coyle et aI., 1984; Coyle, 1986; Brint et aI., 1988; Duverger and MacKenzie, 1988; Graham, 1988; Jacewicz et aI., 1990) . If insufficient numbers of animals are used, a Type II error may complicate statistical testing (i.e., wrongly concluding that no difference exists between treatment and control when, in fact, the sample size is too small to detect a true difference) (Freiman et ai., 1978) . Less well appreciated is the equally important effect of spe cies and stram on drug potency (Grabowski and Jo hannson, 1985) , to which the addition of anesthesia adds another layer of complexity (Goldman and Sa pirstein, 1973; Kanda and Flaim, 1986; Seyde et ai., 1986) . Physiologic variables must be controlled to avoid brain hypothermia (Busto et ai., 1987 (Busto et ai., , 1989 Ginsberg et ai., 1989 ; B. A. Kaplan et ai., in prep aration) and hyperglycemia (Ginsberg et ai., 1980; Pulsinelli et ai., 1982; Prado et ai., 1988) , and if hypotension cannot be avoided, it should be evalu ated for its potential to counteract nimodipine's ce rebrovascular effect (Mohamed et ai., 1984) . A fa vorable outcome is unlikely to occur if the degree and duration of the ischemic insult are not suitably matched by the dosing schedule and mode of deliv ery (e.g., single bolus versus continuous infusion). Finally, timing of nimodipine therapy can have a major impact on the cerebrovascular response, CBF improving with pretreatment but not with posttreatment (Gotoh et ai., 1986; Hakim, 1986; Hakim, 1988, 1989; Dirnagl et ai., 1989) unless adjuvant therapy is added (Salgado et ai., 1989) . It is essential for purposes of drug testing, therefore, that animal models be standardized and every effort made to avoid, or at the very least to investigate, potentially confounding conditions (e.g., brain hypothermia, hypotension, anesthesia).
In conclusion, data from our study demonstrate that nimodipine pretreatment attenuates early focal ischemic injury in awake animals predominantly by improving circulation to the ischemic tissue and per haps by modulating calcium influx in neural tissue as well. Nimodipine delays the rate of edema accumula tion and may also forestall the infarct process, thereby extending the window of therapeutic opportunity. Un less other measures are promptly taken to interrupt ischemia, however, only a modest (20-30%) amount of cortex threatened with infarction will ultimately be salvaged by nimodipine pretreatment.
